Sergei Varshavsky

405 total citations
11 papers, 276 citations indexed

About

Sergei Varshavsky is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Surgery. According to data from OpenAlex, Sergei Varshavsky has authored 11 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 2 papers in Economics and Econometrics and 1 paper in Surgery. Recurrent topics in Sergei Varshavsky's work include Acute Myocardial Infarction Research (4 papers), Heart Failure Treatment and Management (3 papers) and Cardiac pacing and defibrillation studies (2 papers). Sergei Varshavsky is often cited by papers focused on Acute Myocardial Infarction Research (4 papers), Heart Failure Treatment and Management (3 papers) and Cardiac pacing and defibrillation studies (2 papers). Sergei Varshavsky collaborates with scholars based in United Kingdom, United States and Canada. Sergei Varshavsky's co-authors include Marc A. Pfeffer, Robert M. Califf, Scott D. Solomon, Yuri Belenkov, Lars Køber, Rafael Díaz, John J.V. McMurray, Eric J. Velazquez, Marc Henis and Christopher M. O’Connor and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Heart Journal.

In The Last Decade

Sergei Varshavsky

11 papers receiving 262 citations

Peers

Sergei Varshavsky
C. B. Granger United States
Na Yang China
Jan Wintrich Germany
Tushar Acharya United States
G. D. Braatvedt New Zealand
Sergei Varshavsky
Citations per year, relative to Sergei Varshavsky Sergei Varshavsky (= 1×) peers Thomas Melchior

Countries citing papers authored by Sergei Varshavsky

Since Specialization
Citations

This map shows the geographic impact of Sergei Varshavsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergei Varshavsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergei Varshavsky more than expected).

Fields of papers citing papers by Sergei Varshavsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergei Varshavsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergei Varshavsky. The network helps show where Sergei Varshavsky may publish in the future.

Co-authorship network of co-authors of Sergei Varshavsky

This figure shows the co-authorship network connecting the top 25 collaborators of Sergei Varshavsky. A scholar is included among the top collaborators of Sergei Varshavsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergei Varshavsky. Sergei Varshavsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Simes, R. John, Rachel O’Connell, Philip E. Aylward, et al.. (2010). Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. American Heart Journal. 159(6). 988–997. 23 indexed citations
2.
Kenchaiah, Satish, Peter Finn, Jordi Soler‐Soler, et al.. (2010). Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). American Heart Journal. 160(1). 145–151. 28 indexed citations
3.
Morrow, David A., Benjamin M. Scirica, Ewa Karwatowska‐Prokopczuk, et al.. (2007). Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non-ST-Elevation Acute Coronary Syndromes. 21 indexed citations
4.
Domanski, Michaël, Elliott M. Antman, Sonja M. McKinlay, et al.. (2004). Geographic variability in patient characteristics, treatment and outcome in an international trial of magnesium in acute myocardial infarction. Controlled Clinical Trials. 25(6). 553–562. 14 indexed citations
5.
Aguilar, David, Scott D. Solomon, Lars Køber, et al.. (2004). Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction. Circulation. 110(12). 1572–1578. 170 indexed citations
6.
Varshavsky, Sergei, et al.. (2003). Handling Clinical Trial Materials in Russia. Lund University Publications (Lund University). 1 indexed citations
7.
Aguilar, David, Scott D. Solomon, Lars Køber, et al.. (2003). Impact of known and newly diagnosed diabetes mellitus after a myocardial infarction. Journal of the American College of Cardiology. 41(6). 345–346. 1 indexed citations
8.
Simes, John, Harvey D. White, Ian C. Marschner, et al.. (2003). International differences in patients, care and outcomes associated with acute myocardial infarction (AMI): the HERO-2 trial. Heart Lung and Circulation. 12(2). A23–A23. 2 indexed citations
9.
Simes, John, Harvey D. White, Ian C. Marschner, et al.. (2002). International differences in patients, care, and outcomes associated with acute myocardial infarction: the hero-2 trial. Journal of the American College of Cardiology. 39. 280–280. 4 indexed citations
10.
Platonov, Pyotr G., et al.. (2002). Why do patients participate in clinical trials. Lund University Publications (Lund University). 9(11). 11–11. 2 indexed citations
11.
Amir, Marianne, et al.. (1999). Motherland or Home Country. Journal of Cross-Cultural Psychology. 30(6). 712–721. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026